Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 12:41 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 498 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062129 · wk-form4_1789562477.xml · derivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 498 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on September 15, 2023 and vest in three tranches on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| September 15, 2026 Filed Sep 16, 2026 12:41 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 122 | $34.19 | $4,171.18 |
DisclosureSEC source: 0001628280-26-062129 · wk-form4_1789562477.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,028 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| September 15, 2026 Filed Sep 16, 2026 12:41 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 498 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062129 · wk-form4_1789562477.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 11:31 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 2,000 | $31.07 | $62,138.00 |
DisclosureSEC source: 0001628280-26-043718 · wk-form4_1781695915.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 17,917 F4 · kind: The sale of 2,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan"). F5 · price: The price reported in this row represents a weighted average price of $31.069 per share. These shares were sold in multiple transactions at prices ranging from $30.82 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the Reporting Person is a trustee. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 11:31 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 1,681 | $31.07 | $52,223.63 |
DisclosureSEC source: 0001628280-26-043718 · wk-form4_1781695915.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 19,917 F1 · kind: The sale of 1,681 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan"). F2 · price: The price reported in this row represents a weighted average price of $31.067 per share. These shares were sold in multiple transactions at prices ranging from $30.86 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the Reporting Person is a trustee. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:44 UTC |
Palmer Eric PDirector
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029887 · wk-form4_1777927453.xml · derivative · entry 1 Palmer Eric P · CIK 0001710190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:41 UTC |
Hinton James H.Director
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029881 · wk-form4_1777927287.xml · derivative · entry 1 Hinton James H. · CIK 0001905630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
Fontenot Teri G.Director
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029880 · wk-form4_1777927254.xml · derivative · entry 1 Fontenot Teri G. · CIK 0001661066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · derivative · entry 12 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F10 · derivative.exercise_date: The Restricted Stock Units were granted on April 13, 2010 and vest in the incremental amount of 33% on the earlier of (i) April 13, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; 34% on the earlier of (i) April 13, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 13, 2013 or (ii) the date of the Company's 2013 Annual Meeting of Stockholders. At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · derivative · entry 11 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F9 · derivative.exercise_date: The Restricted Stock Units were granted on April 9, 2009 and vest in the incremental amount of 33% on the earlier of (i) April 9, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders; 34% on the earlier of (i) April 9, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 9, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders. At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 6,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · derivative · entry 10 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,009 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F8 · derivative.exercise_date: The Restricted Stock Units were granted on April 8, 2008 and vest in the incremental amount of 33% on the earlier of (i) April 8, 2009 or (ii) the date of the Company's 2009 Annual Meeting of Stockholders; 34% on the earlier of (i) April 8, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 8, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders. At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · derivative · entry 9 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,048 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units were granted on April 18, 2007 and vest in the incremental amount of 33% on the earlier of (i) April 18, 2008 or (ii) the date of the Company's 2008 Annual Meeting of Stockholders; 34% on the earlier of (i) April 18, 2009 or (ii) the date of the Company's 2009 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 18, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders. At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 5,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · derivative · entry 8 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units were granted on April 12, 2006 and vest in the incremental amount of 33% on the earlier of (i) April 12, 2007 and (ii) the date of the Company's 2007 Annual Meeting of Stockholders; 34% on the earlier of (ii) April 12, 2008 and (ii) the date of the Company's 2008 Annual Meeting of Stockholders; and 33% on April 12, 2009. At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · derivative · entry 7 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 9,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · nonDerivative · entry 6 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 9,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · nonDerivative · entry 5 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 6,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · nonDerivative · entry 4 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 4,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · nonDerivative · entry 3 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 5,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · nonDerivative · entry 2 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:40 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029877 · wk-form4_1777927212.xml · nonDerivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:39 UTC |
Trent-Adams SylviaDirector
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029875 · wk-form4_1777927156.xml · derivative · entry 3 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:39 UTC |
Trent-Adams SylviaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029875 · wk-form4_1777927156.xml · derivative · entry 2 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:39 UTC |
Trent-Adams SylviaDirector
|
Exercise / conversionCommon Stock | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029875 · wk-form4_1777927156.xml · nonDerivative · entry 1 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:36 UTC |
Jones Daphne EDirector
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029866 · wk-form4_1777926974.xml · derivative · entry 3 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:36 UTC |
Jones Daphne EDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029866 · wk-form4_1777926974.xml · derivative · entry 2 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:36 UTC |
Jones Daphne EDirector
|
Exercise / conversionCommon Stock | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029866 · wk-form4_1777926974.xml · nonDerivative · entry 1 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:35 UTC |
FOLETTA MARK GDirector
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029865 · wk-form4_1777926930.xml · derivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:35 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029865 · wk-form4_1777926930.xml · derivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock F3 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:35 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionCommon Stock | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029865 · wk-form4_1777926930.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:34 UTC |
Caballero Jorge A.Director
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029864 · wk-form4_1777926884.xml · derivative · entry 3 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:34 UTC |
Caballero Jorge A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029864 · wk-form4_1777926884.xml · derivative · entry 2 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:34 UTC |
Caballero Jorge A.Director
|
Exercise / conversionCommon Stock | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029864 · wk-form4_1777926884.xml · nonDerivative · entry 1 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:33 UTC |
Huber Celia PDirector
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-029860 · wk-form4_1777926802.xml · derivative · entry 1 Huber Celia P · CIK 0002066163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| May 01, 2026 Filed Jul 9, 2026 20:52 UTC Amendment |
Jones Daphne EDirector
|
GrantRestricted Stock Units · Derivative | 8,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047807 · wk-form4a_1783630365.xml · derivative · entry 3 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,304 Underlying: Common Stock · 8,304 shares Expires not disclosed F7 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F8 · derivative.exercise_date: The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed Jul 9, 2026 20:52 UTC Amendment |
Jones Daphne EDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047807 · wk-form4a_1783630365.xml · derivative · entry 2 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 01, 2026 Filed Jul 9, 2026 20:52 UTC Amendment |
Jones Daphne EDirector
|
Exercise / conversionCommon Stock | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047807 · wk-form4a_1783630365.xml · nonDerivative · entry 1 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 16,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Due to an administrative error, the Form 4 filed by the reporting person on May 4, 2026 overstated the amount of securities beneficially owned following the reported transaction by 1,000 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 16,124 securities were beneficially owned by reporting person, not 17,124 as previously reported. F3 · ownership.nature: These shares are held in the Daphne E. Jones Revocable Trust, of which the Reporting Person is the sole trustee and the sole beneficiary. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 19,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · derivative · entry 10 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,282 Underlying: Common Stock · 19,641 shares Expires not disclosed F8 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F9 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · derivative · entry 9 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,182 Underlying: Common Stock · 3,537 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · derivative · entry 8 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772 Underlying: Common Stock · 749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 202 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · derivative · entry 7 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 1,049 | $19.55 | $20,507.95 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · nonDerivative · entry 6 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,652 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 3,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · nonDerivative · entry 5 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 223 | $19.55 | $4,359.65 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · nonDerivative · entry 4 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,164 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · nonDerivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 60 | $19.55 | $1,173.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,638 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 202 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002302 · wk-form4_1768581451.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 14:18 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantRestricted Stock Units · Derivative | 36,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002280 · wk-form4_1768573095.xml · derivative · entry 10 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,656 Underlying: Common Stock · 36,828 shares Expires not disclosed F8 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F9 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 14:18 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 6,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002280 · wk-form4_1768573095.xml · derivative · entry 9 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,467 Underlying: Common Stock · 6,632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 14:18 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002280 · wk-form4_1768573095.xml · derivative · entry 8 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,317 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 14:18 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002280 · wk-form4_1768573095.xml · derivative · entry 7 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.